Literature DB >> 8931869

The occurrence of cutaneous nerve endings and neuropeptides in vitiligo vulgaris: a case-control study.

P Y Liu1, L Bondesson, W Löntz, O Johansson.   

Abstract

Pioneering studies both in humans and animals have demonstrated an association between the peripheral nervous system and epidermal melanocyte destruction. The presence of certain neuropeptides and neuronal structural markers in peripheral nerve fibres was investigated in involved and uninvolved vitiligo skin and compared with normal healthy skin. A group of 18 vitiligo vulgaris patients and matched healthy volunteers participated in the investigation. The indirect immunofluorescence technique was employed. There was a tendency for a reduction in the number and intensity of low affinity (p75) nerve growth factor receptor immunoreactive (NGFr-IR) basal keratinocytes in involved vitiliginous skin (P < 0.06) compared with control skin, while the number of NGFr-IR nerve fibres was significantly increased (P < 0.01). The number of calcitonin gene-related peptide (CGRP)-IR nerve fibres in the epidermis and papillary dermis was dramatically increased in involved skin as compared with control skin (P < 0.01) and with uninvolved skin (P < 0.05). No clear difference could be found in the distribution of vasoactive intestinal polypeptide (VIP)- and neuropeptide tyrosine (NPY)-IR nerve fibres. A different structural appearance of the peripheral nervous system as well as a changed balance of neuropeptides in vitiliginous skin point to a critical role of the nervous system in the pathogenesis of vitiligo.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8931869     DOI: 10.1007/bf02505276

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  24 in total

1.  Exchange grafts in vitiligo.

Authors:  G A SPENCER; J A TOLMACH
Journal:  J Invest Dermatol       Date:  1952-07       Impact factor: 8.551

2.  Physiologic changes in vitiligo.

Authors:  M L Chanco-Turner; A B Lerner
Journal:  Arch Dermatol       Date:  1965-04

3.  Vitiligo and sympathectomy. The effect of sympathectomy and alpha- melanocyte stimulating hormone.

Authors:  A B Lerner; R S Snell; M L Chanco-Turner; J S McGuire
Journal:  Arch Dermatol       Date:  1966-09

4.  Poliosis overlying a neurofibroma.

Authors:  B S Koplon; L Shapiro
Journal:  Arch Dermatol       Date:  1968-12

5.  Morphological characterization of the somatostatin-immunoreactive dendritic skin cells in urticaria pigmentosa patients by computerized image analysis.

Authors:  O Johansson
Journal:  Scand J Immunol       Date:  1985-05       Impact factor: 3.487

Review 6.  Chemistry of melanin-concentrating hormone.

Authors:  H Kawauchi; N Naito; M Ono
Journal:  Ann N Y Acad Sci       Date:  1993-05-31       Impact factor: 5.691

7.  Vitiligo. Clinical picture and pathogenesis.

Authors:  E I McBurney
Journal:  Arch Intern Med       Date:  1979-11

8.  Vitiligo: a new classification and therapy.

Authors:  M Koga
Journal:  Br J Dermatol       Date:  1977-09       Impact factor: 9.302

9.  Plasma alpha-melanocyte-stimulating hormone, beta-endorphin, met-enkephalin, and natural killer cell activity in vitiligo.

Authors:  N Mozzanica; M L Villa; S Foppa; G Vignati; A Cattaneo; R Diotti; A F Finzi
Journal:  J Am Acad Dermatol       Date:  1992-05       Impact factor: 11.527

10.  Evidence for nerve growth factor-mediated paracrine effects in human epidermis.

Authors:  M Yaar; K Grossman; M Eller; B A Gilchrest
Journal:  J Cell Biol       Date:  1991-11       Impact factor: 10.539

View more
  6 in total

Review 1.  Hypopigmentary skin disorders: current treatment options and future directions.

Authors:  Anke Hartmann; Eva-B Bröcker; Jürgen C Becker
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 2.  New treatment modalities for vitiligo: focus on topical immunomodulators.

Authors:  Kresimir Kostovic; Aida Pasic
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  The Efficacy and Psychoneuroimmunology Mechanism of Camouflage Combined With Psychotherapy in Vitiligo Treatment.

Authors:  Yuqian Chang; Shaolong Zhang; Weigang Zhang; Shuli Li; Chunying Li
Journal:  Front Med (Lausanne)       Date:  2022-05-27

4.  Understanding mechanisms of vitiligo development in Smyth line of chickens by transcriptomic microarray analysis of evolving autoimmune lesions.

Authors:  Fengying Shi; Byung-Whi Kong; Joon Jin Song; Jeong Yoon Lee; Robert L Dienglewicz; Gisela F Erf
Journal:  BMC Immunol       Date:  2012-04-13       Impact factor: 3.615

5.  NPY Gene Polymorphism in Vitiligo: A Case-Control Study in Egyptian Patients.

Authors:  Ola Bakry; Alaa Mariee; Iman Badr; Nermin Tayel; Samar El Gendy
Journal:  Indian J Dermatol       Date:  2020 Jan-Feb       Impact factor: 1.494

6.  Association of neuropeptide Y (NPY), interleukin-1B (IL1B) genetic variants and correlation of IL1B transcript levels with vitiligo susceptibility.

Authors:  Naresh C Laddha; Mitesh Dwivedi; Mohmmad Shoab Mansuri; Mala Singh; Hetanshi H Patel; Nishtha Agarwal; Anish M Shah; Rasheedunnisa Begum
Journal:  PLoS One       Date:  2014-09-15       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.